150 related articles for article (PubMed ID: 17095966)
1. [Breast carcinoma and bone chondrosarcoma: a new syndrome?].
Guedin P; Chasle J; Blanc-Fournier C; Lacroix J
J Radiol; 2006 Nov; 87(11 Pt 1):1700-4. PubMed ID: 17095966
[TBL] [Abstract][Full Text] [Related]
2. [A case of inflammatory breast cancer achieving pathological complete response by primary systemic therapy with CEF (cyclophosphamide, epirubicin, 5-fluorouracil) followed by docetaxel].
Sagara Y; Rai Y; Sagara Y; Tamada S; Tsuchimochi S; Takahama T; Matsuyama Y; Ando M; Ooi Y; Sagara Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):77-80. PubMed ID: 17220675
[TBL] [Abstract][Full Text] [Related]
3. Low-grade chondrosarcoma mimicking breast cancer.
El Hammoumi MM; Mohammed B; Ochi RE; Oukabli M; Kabiri EH
Asian Cardiovasc Thorac Ann; 2021 Feb; 29(2):125-127. PubMed ID: 33131290
[TBL] [Abstract][Full Text] [Related]
4. [A case of breast cancer with chronic renal failure successfully treated with TC therapy as adjuvant chemotherapy].
Oshiro C; Arai T; Kamigaki S; Matsuura M
Gan To Kagaku Ryoho; 2012 Feb; 39(2):265-7. PubMed ID: 22333640
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
6. A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy.
Maciá Escalante S; Rodríguez Lescure A; Pons Sanz V; Martínez Banaclocha N; Guillén Ponce C; Carrato Mena A
Clin Transl Oncol; 2006 Oct; 8(10):761-3. PubMed ID: 17074677
[TBL] [Abstract][Full Text] [Related]
7. A remarkable case of cutaneous metastatic breast carcinoma.
Santiago F; Saleiro S; Brites MM; Frutuoso C; Figueiredo A
Dermatol Online J; 2009 Jul; 15(7):10. PubMed ID: 19903438
[TBL] [Abstract][Full Text] [Related]
8. [Response evaluation with mammography and ultrasound].
Junkermann H; Schmid H; Sinn HP; Wallwiener D
Zentralbl Gynakol; 1996; 118(10):572-3. PubMed ID: 8999712
[No Abstract] [Full Text] [Related]
9. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
Yagata H; Kajiura Y; Yamauchi H
Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
[TBL] [Abstract][Full Text] [Related]
10. [Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
Yuan P; Xu BH; Wang JY; Ma F; Li Q; Zhang P; Fan Y; Li Q; Wang WM
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):465-8. PubMed ID: 22967451
[TBL] [Abstract][Full Text] [Related]
11. [Breast carcinoma in accessory gland: a case report].
Sivelli R; Del Rio P; Arcuri MF; Corcione L
G Chir; 2002 May; 23(5):179-80. PubMed ID: 12228967
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated chondrosarcoma: an aggressive variant of chondrosarcoma.
Bharath G; Burrah R; Shivakumar K; Manjunath S; Bhanumathi R
Asian Cardiovasc Thorac Ann; 2015 Feb; 23(2):221-3. PubMed ID: 24585295
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
14. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
15. Accessory breast tissue in axilla masquerading as breast cancer recurrence.
Goyal S; Puri T; Gupta R; Julka PK; Rath GK
J Cancer Res Ther; 2008; 4(2):95-6. PubMed ID: 18688128
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer].
Wang B; Fu JF; Hong ZW
Ai Zheng; 2009 Mar; 28(3):292-6. PubMed ID: 19619445
[TBL] [Abstract][Full Text] [Related]
17. Case records of the Massachusetts General Hospital. Case 35-2005. A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node.
Davidson NE; Morrow M; Kopans DB; Koerner FC
N Engl J Med; 2005 Nov; 353(20):2177-85. PubMed ID: 16291988
[No Abstract] [Full Text] [Related]
18. Case of epirubicin-induced cardiomyopathy in familial cardiomyopathy.
Shipman KE; Arnold I
J Clin Oncol; 2011 Jun; 29(18):e537-8. PubMed ID: 21482996
[No Abstract] [Full Text] [Related]
19. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
20. Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancer.
Liljegren A; Bergh J; Castany R
Breast; 2009 Aug; 18(4):259-62. PubMed ID: 19744626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
